Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03345849
What this trial is testing

The Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Who this might be right for
Crohn's Disease
AbbVie 526
Large-scale testing (Phase 3)Looking for participantsNCT07196722
What this trial is testing

Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 1,092
Not applicableLooking for participantsNCT07545317
What this trial is testing

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University 665
Testing effectiveness (Phase 2)Study completedNCT01783106
What this trial is testing

Antibiotics and Hydroxychloroquine in Crohn's

Who this might be right for
Crohn's Disease
Royal Liverpool University Hospital 59
Testing effectiveness (Phase 2)Ended earlyNCT05068284
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 176
Large-scale testing (Phase 3)Study completedNCT00048295
What this trial is testing

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Ionis Pharmaceuticals, Inc. 150
Post-approval studies (Phase 4)Looking for participantsNCT07564505
What this trial is testing

A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease

Who this might be right for
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Not applicableLooking for participantsNCT05321758
What this trial is testing

Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

Who this might be right for
Crohn Disease
Tongji Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00655135
What this trial is testing

Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's Patients

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 185
Not applicableNot Yet RecruitingNCT06917443
What this trial is testing

Abdominally Targeted Management Exercises for Crohn's Disease Patients (TAME-CD)

Who this might be right for
Crohn Disease (CD)IBD (Inflammatory Bowel Disease)
Shmuel Kivity, MD 42
Early research (Phase 1)Study completedNCT02968108
What this trial is testing

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 45
Not applicableLooking for participantsNCT07504510
What this trial is testing

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Who this might be right for
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University 300
Testing effectiveness (Phase 2)Ended earlyNCT00584740
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT01957423
What this trial is testing

Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.

Who this might be right for
Crohn's Disease
University of Campinas, Brazil 41
Large-scale testing (Phase 3)Study completedNCT00207662
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 580
Testing effectiveness (Phase 2)Study completedNCT00287170
What this trial is testing

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

Who this might be right for
Crohn's Disease
Teva GTC 15
Not applicableStudy completedNCT01942720
What this trial is testing

Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

Who this might be right for
Known Crohn Disease Subjects
Medtronic - MITG 74
Not applicableUnknownNCT02926300
What this trial is testing

Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)

Who this might be right for
Crohn's Disease
Kang Stem Biotech Co., Ltd. 24
Not applicableLooking for participantsNCT07522528
What this trial is testing

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

Who this might be right for
Crohn's Disease (CD)
University of Glasgow 90
Large-scale testing (Phase 3)Study completedNCT03234907
What this trial is testing

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Who this might be right for
Crohn's Disease
Takeda 215
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation